Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Other ETFs median (248 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 31 Mar 2021 – 20 Aug 2026, limited by Axis NIFTY IT ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Axis NIFTY IT ETF | Nifty 500 |
|---|---|---|
| 31 Mar 2021 | ₹100.00 | ₹100.00 |
| 11 Sep 2021 | ₹135.59 | ₹120.49 |
| 22 Feb 2022 | ₹133.82 | ₹117.67 |
| 05 Aug 2022 | ₹119.11 | ₹121.01 |
| 16 Jan 2023 | ₹116.97 | ₹124.30 |
| 29 Jun 2023 | ₹116.14 | ₹132.19 |
| 10 Dec 2023 | ₹135.49 | ₹151.89 |
| 22 May 2024 | ₹137.10 | ₹172.47 |
| 02 Nov 2024 | ₹166.72 | ₹185.35 |
| 15 Apr 2025 | ₹137.87 | ₹172.81 |
| 26 Sep 2025 | ₹141.02 | ₹184.45 |
| 09 Mar 2026 | ₹127.74 | ₹179.12 |
| 20 Aug 2026 | ₹130.86 | ₹190.95 |
| Metric | Axis NAV ₹338.23 Very High risk ★☆☆☆☆ | Category median Other ETFs · 248 funds |
|---|---|---|
| -12.40% | +3.65% | |
| +1.95% | +10.51% | |
| +0.14% | +9.28% | |
| — | +11.93% | |
| +5.12% | +10.38% | |
| -1.49% | — | |
| +7.65% | +14.30% | |
| +2.68% | +13.74% | |
| — | +12.83% | |
| Risk | ||
| 21.94% | 15.45% | |
| -0.21 | 0.28 | |
| -0.30 | 0.41 | |
| -42.17% | -20.59% | |
| Nifty 500 | — | |
| -6.34% | +0.80% | |
| 0.76 | 1.00 | |
| 40.8% | 102.1% | |
| 63.5% | 96.4% | |
| 0.51% | 0.32% | |
| ₹144.28Cr | ₹137.31Cr | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| Karthik Kumar | — | |
| 31 Mar 2021 | — | |
| 10 | — | |
| 99.8% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.